BIO-B vs PARAP
Comparison between Bio-Rad Laboratories Inc - Class B (BIO-B, Company) and Paramount Global Conv Pfd (PARAP, Company).
BIO-B vs PARAP - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
BIO-B
$9.01B
PARAP
$8.99B
Max Drawdown
Winner
BIO-B
72.48%
PARAP
77.73%
Sharpe Ratio
Winner
BIO-B
0.94
PARAP
-0.81
5Y Beta
BIO-B
-0.04
PARAP
N/A
Industry
BIO-B
Medical Devices
PARAP
N/A
P/E Ratio
BIO-B
-50.35
Winner
PARAP
-1320.95
Forward P/E
BIO-B
36.90
PARAP
N/A
Debt to Equity
Winner
BIO-B
11.19%
PARAP
65.40%
Free Cash Flow Yield
BIO-B
3.92%
Winner
PARAP
8.96%
P/S Ratio
BIO-B
N/A
PARAP
0.30
P/B Ratio
BIO-B
N/A
PARAP
0.39
BIO-B vs PARAP - Historical Returns
Returns include dividend reinvestment.
1M
Winner
BIO-B
+8.93%
PARAP
+4.39%
3M
Winner
BIO-B
+31.88%
PARAP
-19.91%
6M
Winner
BIO-B
+31.10%
PARAP
-7.79%
1Y
Winner
BIO-B
+36.41%
PARAP
-37.02%
5Y(CAGR)
BIO-B
-15.08%
PARAP
N/A
10Y(CAGR)
BIO-B
+8.18%
PARAP
N/A
Max(CAGR)
Winner
BIO-B
+13.40%
PARAP
-32.88%
BIO-B vs PARAP - Annual Returns (1999 - 2026)
Returns include dividend reinvestment.
| Year | BIO-B | PARAP |
|---|---|---|
| 2026 | +8.46% | N/A |
| 2025 | -4.58% | N/A |
| 2024 | +1.54% | -18.72% |
| 2023 | -20.76% | -6.69% |
| 2022 | -44.94% | -45.29% |
| 2021 | +25.91% | N/A |
| 2020 | +54.89% | N/A |
| 2019 | +60.70% | N/A |
| 2018 | -3.46% | N/A |
| 2017 | +30.08% | N/A |
| 2016 | +33.03% | N/A |
| 2015 | +14.67% | N/A |
| 2014 | -2.37% | N/A |
| 2013 | +15.80% | N/A |
| 2012 | +6.31% | N/A |
| 2011 | -9.98% | N/A |
| 2010 | +6.86% | N/A |
| 2009 | +31.80% | N/A |
| 2008 | -30.83% | N/A |
| 2007 | +28.86% | N/A |
| 2006 | +28.31% | N/A |
| 2005 | +14.04% | N/A |
| 2004 | -2.64% | N/A |
| 2003 | +36.47% | N/A |
| 2002 | +32.81% | N/A |
| 2001 | +103.17% | N/A |
| 2000 | +36.25% | N/A |
| 1999 | -0.56% | N/A |
BIO-B vs PARAP Drawdown Comparison
The maximum drawdown for BIO-B was -72.48%, occurring on Apr 9, 2025. This drawdown has not yet recovered.
The maximum drawdown for PARAP was -66.20%, occurring on Mar 5, 2024. This drawdown has not yet recovered.
The current BIO-B drawdown is -58.83%. The current PARAP drawdown is -61.42%.
| Rank | BIO-B | PARAP |
|---|---|---|
| #1 | -72.48% Sep 10, 2021 - Apr 9, 2025 | -66.20% Mar 3, 2022 - Mar 5, 2024 |
| #2 | -50.14% Aug 11, 2008 - Apr 20, 2010 | -4.00% Feb 17, 2022 - Feb 25, 2022 |
| #3 | -35.34% Mar 1, 2000 - Nov 29, 2000 | N/A |
| #4 | -34.33% Jun 19, 2002 - May 20, 2003 | N/A |
| #5 | -31.86% Sep 4, 2018 - Aug 2, 2019 | N/A |
| #6 | -31.00% May 3, 2011 - Jan 9, 2014 | N/A |
| #7 | -27.68% Nov 8, 2007 - Aug 11, 2008 | N/A |
| #8 | -25.78% May 3, 2010 - Mar 7, 2011 | N/A |
| #9 | -23.33% Dec 26, 2003 - Aug 2, 2005 | N/A |
| #10 | -22.65% Feb 1, 2007 - Sep 27, 2007 | N/A |
| #11 | -20.71% May 17, 2002 - Jun 17, 2002 | N/A |
| #12 | -19.75% Feb 18, 2020 - Apr 14, 2020 | N/A |
| #13 | -19.59% Jun 6, 2003 - Dec 26, 2003 | N/A |
| #14 | -18.74% Feb 20, 2014 - Mar 12, 2015 | N/A |
| #15 | -18.70% Nov 6, 2020 - Feb 12, 2021 | N/A |
Correlation
Correlation between BIO-B and PARAP is 0.93 which considered as a very strong positive correlation - the stocks move almost identically together.
0.93
-101
Select Stocks to Compare
Popular: BIO-B vs SPYPARAP vs SPY
More Comparisons
Compare with similar stocks